A blog about chemistry, drug development, science, and technology
I reported on pharming before but wanted to point out this latest article from the Times of London.
‘Pharm’ goats give birth to new drugs - Sunday Times - Times Online
The drug being produced is ATryn, an anti-clotting drug used to treat patients with hereditary antithrombin deficiency (HAD). This makes the patients vulnerable to deep-vein thrombosis. The drug is being developed by a US company called GTC Biotherapeutics.
There is also mentioned another company developing the drug Rhucin for treatment of angioedema (swelling of soft tissue). This is being developed by the Dutch company Pharming.
It is great to note that these life-savings drugs are being approved. I would note that this really only applies to biologics. I can’t see small molecules being produced in this way anytime in the near future.
Other resources
Technorati Tags: ATryn, GTC Biotherapeutics, pharming, Rhucin, transgenic animals
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.151 seconds